Frank Buttgereit

Frank Buttgereit is a prominent academic figure at Freie Universität Berlin, where they contribute to the Rheumatology through intensive research in rheumatoid arthritis, systemic lupus erythematosus, polymyalgia rheumatica, glucocorticoid therapy, adrenal hormones, clinical guidelines, 11β-hydroxysteroid dehydrogenase, osteoporosis. A representative example of their recent contribution is the study titled "Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica", which offers critical insights into the dynamics of rheumatoid arthritis and systemic lupus erythematosus. Additional work such as "Osteoporosis and fracture risk are multifactorial in patients with inflammatory rheumatic diseases" further demonstrates their commitment to advancing knowledge in this domain.